|
KMID : 1022820210120020039
|
|
Journal of Multiple Sclerosis and Neuroimmunology
2021 Volume.12 No. 2 p.39 ~ p.42
|
|
|
Successful Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Rituximab
|
|
Kim Da-Young
Choi Kyo-Min
Oh Jee-Young
|
|
|
Abstract
|
|
|
|
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a heterogeneous autoimmune disease characterized by a relapsing and remitting or progressive pattern. Corticosteroid, intravenous immunoglobulin or plasma exchange are usually used as treatment options. However, approximately one-third of patients with CIDP have an inadequate response to standard treatments. Rituximab, a monoclonal antibody against CD20, has been used with good results in some patients with refractory CIDP. We report a patient with refractory CIDP in whom remission has been successfully maintained after treatment with rituximab.
|
|
|
KEYWORD
|
|
|
Polyradiculoneuropathy, Chronic inflammatory demyelinatin, Rituximab
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|